Chlorhexidine + Climbazole + Phytosphingosine

14 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

ChlorhexidineClimbazolePhytosphingosine

Administration Routes

Topical

Species Affected

Dog 13

Cat 1

Most Affected Breeds

Bulldog - French 3

Crossbred Canine/dog 2

Dog (other) 1

Terrier - Cairn 1

Sphynx 1

Spitz - German Pomeranian 1

Shih Tzu 1

Maltese 1

Chihuahua 1

Mixed (Dog) 1

Most Reported Reactions

Erythema (for urticaria see Immune SOC) 6

Pruritus 5

Hair coat discolouration 4

Skin irritation 2

Application site weeping (see also 'skin') 1

Rash 1

Application site rash 1

Lack of efficacy - NOS 1

Behavioural disorder NOS 1

Discomfort NOS 1

Vocalisation 1

Application site scratching 1

Outcome Breakdown

Recovered/Normal

6 (42.9%)

Outcome Unknown

6 (42.9%)

Recovered with Sequela

2 (14.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.